Related Experiment Video
Updated: Apr 27, 2026

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Relapsing polymyositis in chronic graft versus host disease
Nematullah Sharaf1, Richard A Prayson1
1Cleveland Clinic Lerner College of Medicine and Department of Anatomic Pathology, Cleveland Clinic Main Campus, Mail Code L25, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Chronic graft-versus-host disease (GVHD) can manifest as polymyositis, a rare skeletal muscle complication after stem cell transplants. This case highlights a patient who relapsed after steroid tapering, underscoring the challenges in managing this condition.
Area of Science:
- Immunology
- Oncology
- Neurology
Background:
- Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapy for hematologic malignancies.
- Chronic graft-versus-host disease (GVHD) remains a significant cause of long-term morbidity and mortality post-HSCT.
- Skeletal muscle involvement in chronic GVHD is uncommon, with polymyositis being a rare presentation.
Observation:
- A 54-year-old male with acute myeloid lymphoma underwent HSCT.
- The patient developed acute gastrointestinal GVHD and subsequently polymyositis.
- Polymyositis recurred upon reduction of immunosuppressive steroid therapy.
Findings:
- This case illustrates a rare manifestation of chronic GVHD presenting as polymyositis.
- The patient experienced a relapse of polymyositis, indicating a potential challenge in treatment management.
- Steroid tapering was associated with disease recurrence.
Implications:
- Early recognition of polymyositis in chronic GVHD patients is crucial for timely intervention.
- Management strategies for polymyositis in chronic GVHD may require prolonged or adjusted immunosuppression.
- Further research into the pathogenesis and optimal treatment of GVHD-induced polymyositis is warranted.
Related Concept Videos
Cell-mediated Immune Responses
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis ll: Pathophysiology
Myocarditis III: Medical Management
Chronic Inflammation: Introduction
Myocarditis I: Introduction

